Atham Ali, PhD, is a Senior Alliance Associate at Arrowhead Pharmaceuticals, where responsibilities have included roles as Alliance Associate and Program Management Intern since February 2023. As a PhD researcher at the University of Southern California from August 2019 to May 2024, Atham's research focuses on the therapeutic potential of targeting multiple receptors in acute myeloid leukemia cells, specifically utilizing elastin-like polypeptides fused to single chain variable fragments. Previous experience includes serving as a Laboratory Assistant at the University of California, Irvine, where Atham contributed to developing innovative methods for determining receptor-state affinities, and as a Medical Laboratory Scientist at Q² Solutions, investigating vaccine efficacy against the Dengue Virus. Atham holds a PhD in Pharmaceutical Sciences from USC Alfred E. Mann School of Pharmacy and a BS in Public Health Science from UC Irvine.
This person is not in any teams
This person is not in any offices